The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Estimation of Infarct Size in Man and its Relation to Prognosis
Open accessAbstract
Infarct size was assessed quantitatively in 33 patients with acute myocardial infarction with a new technic based on analysis of serial serum creatine phosphokinase (CPK) changes to determine its relationship to prognosis. We have recently measured infarct size in the conscious dog with this method which takes into account CPK distribution space, fractional disappearance rate, proportion degraded in myocardium, and proportion released into the circulation, and we have validated the method by measurement of myocardial CPK depletion in the same animals. In the present study, CPK activity (determined spectrophotometrically) and isoenzyme profiles (assayed electrophoretically) were measured in patient serum samples obtained every 2 hours. Infarct size was estimated by mathematical analysis of serial CPK changes utilizing the method previously developed in the conscious dog model. CPK isoenzyme profiles demonstrated prominent anodal bands, absent from normal serum, indicating that enzyme elevations reflected CPK released from heart rather than skeletal muscle. In 19 class I-II survivors (New York Heart Association) estimated infarct size was 31 ± 4 CPK-gram-equivalents (CPK-g-Eq). It was significantly larger ( P < 0.01), 103 ± 14, in nine patients who died and in four class III or IV survivors (91 ± 8). Estimation of cumulative infarct size differentiated patients with electrocardiographic changes and clinical sequelae from complications such as pericarditis from those patients with extension of infarction. Thus, infarct size can be assessed quantitatively in patients with acute myocardial infarction and provide a useful diagnostic and prognostic index based on the extent of myocardial damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions
MAROKO, P. R., KJEKSHUS, J. K., SOBEL, B. E., WATANABE, T., COVELL, J. W., ROSS, J., & BRAUNWALD, E. (1971) · Circulation · doi:10.1161/01.cir.43.1.67 · Cited by 1,486
Self-citationMyocardial Changes Associated with Cardiogenic Shock
Page, D. L., Caulfield, J. B., Kastor, J. A., DeSanctis, R. W., & Sanders, C. A. (1971) · New England Journal of Medicine · doi:10.1056/nejm197107152850301 · Cited by 678
Shell, W. E., Kjekshus, J. K., & Sobel, B. E. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106762 · Cited by 519
Self-citationMAROKO, P. R., LIBBY, P., SOBEL, B. E., BLOOR, C. M., SYBERS, H. D., SHELL, W. E., COVELL, J. W., & BRAUNWALD, E. (1972) · Circulation · doi:10.1161/01.cir.45.6.1160 · Cited by 295
Self-citation
Cited by
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., & Christenson, R. H. (2007) · Circulation · doi:10.1161/circulationaha.107.182882 · Cited by 610
Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-894 · Cited by 584
Intracoronary thrombolysis in evolving myocardial infarction
Ganz, W., Buchbinder, N., Marcus, H., Mondkar, A., Maddahi, J., Charuzi, Y., O'Connor, L., Shell, W., Fishbein, M. C., Kass, R., et al. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90376-8 · Cited by 584
Self-citationAsinger, R. W., Mikell, F. L., Elsperger, J., & Hodges, M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108063050601 · Cited by 580
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Lai, R. C., Chen, T. S., & Lim, S. K. (2011) · Regenerative Medicine · doi:10.2217/rme.11.35 · Cited by 553
Ovize, M., Baxter, G. F., Di Lisa, F., Ferdinandy, P., Garcia-Dorado, D., Hausenloy, D. J., Heusch, G., Vinten-Johansen, J., Yellon, D. M., & Schulz, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq129 · Cited by 502
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., Christenson, R. H., NACB COMMITTEE MEMBERS, et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084194 · Cited by 474
Habib, G. B., Heibig, J., Forman, S. A., Brown, B. G., Roberts, R., Terrin, M. L., & Bolli, R. (1991) · Circulation · doi:10.1161/01.cir.83.3.739 · Cited by 429
The quantification of infarct size
Gibbons, R. J., Valeti, U. S., Araoz, P. A., & Jaffe, A. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.071 · Cited by 356
EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION
Yusuf, S., Peto, R., Bennett, D., Ramsdale, D., Furse, L., Bray, C., & Sleight, P. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90231-7 · Cited by 320
Ideker, R. E., Wagner, G. S., Ruth, W. K., Alonso, D. R., Bishop, S. P., Bloor, C. M., Fallon, J. T., Gottlieb, G. J., Hackel, D. B., Phillips, H. R., et al. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90235-1 · Cited by 273
LEE, T. H., & GOLDMAN, L. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-221 · Cited by 264
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
Roe, M. T., Ohman, E. M., Maas, A. C. P., Christenson, R. H., Mahaffey, K. W., Granger, C. B., Harrington, R. A., Califf, R. M., & Krucoff, M. W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01101-3 · Cited by 258
Metadata
- Authors
- SOBEL, B. E., BRESNAHAN, G. F., SHELL, W. E., & YODER, R. D.
- Venue
- Circulation
- Published
- 1972-10
- Volume
- 46
- Issue
- 4
- Pages
- 640-648
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2043511280
- Cited by
- 715
- References
- 4
- FWCI
- 23.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.